To Evaluate Safety and Efficacy of a Radiofrequency Renal Denervation System in Treatment of Essential Hypertension

NACompletedINTERVENTIONAL
Enrollment

205

Participants

Timeline

Start Date

January 19, 2021

Primary Completion Date

December 26, 2022

Study Completion Date

December 26, 2022

Conditions
Hypertension
Interventions
DEVICE

Renal Artery Radiofrequency Ablation System (Generator and Catheter )

A renal denervation system with a mesh 6-electrode radiofrequency ablation catheter and multi-channel radiofrequency generator

DRUG

Antihypertensive Agents

Calcium channel blocker, Diuretic

DEVICE

Sham Procedure

Catheterization without renal denervation

Trial Locations (25)

100005

Tangdu Hospital, Fourth Military Medical University, Xi’an

100029

Beijing Anzhen Hospital, Capital Medical University, Beijing

100853

Chinese PLA General Hospital, Beijing

200065

Shanghai Tongji Hospital, Shanghai

200940

Shanghai First People's Hospital, Shanghai

210009

Zhongda Hospital, Southeast University, Nanjing

250012

Qilu Hospital of Shandong University, Jinan

266042

Qingdao Central Hospital, Qingdao

272002

The First People's Hospital of Jining, Shandong Province, Jining

274099

Heze Municipal Hospital, Heze

300022

Tianjin Chest Hospital, Tianjin

310020

Run Run Shaw Hospital, Zhejiang University School of Medicine, Hanzhou

450016

The Seventh People's Hospital of Zhengzhou, Zhengzhou

450052

The 1st Affiliated Hospital Zhengzhou University, Zhengzhou

473009

Nanyang Second People's Hospital, Nanyang

610044

Huaxi Hospital, Chengdu

716099

Xianyang Hospital of Yan 'an University, Yanan

730030

Lanzhou University Second Hospital, Lanzhou

750003

General Hospital of Ningxia Medical University, Yinchuan

830011

The First Affiliated Hospital of Xinjiang Medical University, Ürümqi

Xinjiang Autonomous Region People's Hospital, Ürümqi

050030

Shijiazhuang People's Hospital, Shijiazhuang

030001

The Second Affiliated Hospital of Shanxi Medical University, Taiyuan

030032

Shanxi Bethune Hospital, Taiyuan

044099

Yuncheng Central Hospital, Yuncheng

All Listed Sponsors
lead

Shanghai Golden Leaf MedTec Co. Ltd

INDUSTRY

NCT03261375 - To Evaluate Safety and Efficacy of a Radiofrequency Renal Denervation System in Treatment of Essential Hypertension | Biotech Hunter | Biotech Hunter